Carbenoxolone does not cross the blood brain barrier: An HPLC study

BMC Neuroscience

Volumn 7, Issue , 2006, Pages

  Leshchenko, Yevgen ^a   Likhodii, Sergei ^a   Yue, Wendy ^a   Burnham, William M ^a   Perez Velazquez, Jose L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENOXOLONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CISTERNA MAGNA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG MECHANISM; DRUG PENETRATION; GAP JUNCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CARBENOXOLONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INJECTIONS, INTRAPERITONEAL; MALE; OSMOLAR CONCENTRATION; RATS; RATS, LONG-EVANS; TIME FACTORS;

EID: 32044465504     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-7-3     Document Type: Article

References (17)

1. Davidson JS, Baumgarten JM: Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap junctional intercellular communication: Structure-activity relationship. J Pharm Exper Therapeutics 1988, 246:1104.
2. Sewell KJ, Shirly DG, Michael AE, Thompson A, Norgate DP, Unwin RJ: Inhibition of renal 11-beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion. Clin Sci 1998, 95:435-443.
3. Rozental R, Srinivas M, Spray DC: How to close a gap junction channel: Efficacies and potencies of uncoupling agents. Methods Mol Biol 2001, 154:447-476.
4. Bani-Yaghoub M, Underhill TM, Naus CCG: Gap junction blockage interferes with neuronal and astroglial differentiation ofmouse P19 embryonal carcinoma cells. Dev Genetics 1999, 24:69-81.
5. Frantseva MV, Kokarovtseva L, Naus CCG, Carlen PL, MacFabe D, Perez Velazquez JL: Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neurosci 2002, 22:644-653.
6. Ross FM, Gwyn P, Spanswick D, Davies SN: Carbenoxolone depresses spontaneous epileptiform activity in the CAI region of rat hippocampal slices. Neuroscience 2000, 100:789-796.
7. Szente M, Gajda Z, Said Ali K, Hermesz E: Involvement of electrical coupling in the in vivo ictal epileptiform activity induced by 4-aminopyridine in the neocortex. Neuroscience 2002, 115:1067-1078.
8. Gareri P, Condorelli D, Belluardo N, Russo E, Loiacono A, Barresi V, Trovato-Salinato A, Mirone MB, Ibbadu GF, De Sarro G: Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats. Neuropharmacology 2004, 47:1205-1216.
9. Gareri P, Condorelli D, Belluardo N, Citraro R, Barresi V, Trovato-Salinato A, Mudò G, Ibbadu GF, Russo E, De Sarro G: Antiabsense effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology 2005 in press.
10. Gajda Z, Gyengési E, Hermesz E, Said Ali K, Szente M: Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo. Epilepsia 2003, 44:1596-1600.
11. Moore H, Grace AA: A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated sterotypies. Neuropsychopharmacology 2002, 27:980-992.
12. Jellinck PH, Monder C, McEwen BS, Sakai RR: Differential inhibition of 11β-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J Steroid Biochem Molec Biol 1993, 46:209-213.
13. Zhang Y: Determination of furazolidone, carbenoxolone sodium and berberine hydrochloride in wei kang tablets by reversed-phase high performance liquid chromatography (RP-HPLC). Chinese J Chromatography 2002, 20:350-352.
14. Likhodii S, Sebanesku I, Cortez M, Murphy P, Snead C, Burnham M: Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 2003, 54:219-226.
15. Hosseinzadeh H, Nassiri AM: Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol 2003, 3:3-13.
16. Saito R, Graf R, Hubel K, Fujita T, Rosner G, Heiss WD: Reduction of infarct volume by halothane: effect on cerebral blood flow or perifocal spreading depression-like depolarizations. J Cereb Blood Flow Metab 1997, 17:857-864.
17. Perez Velazquez JL, Frantseva MV, Naus CCG: Gap junctions and neuronal injury: protectants or executioners? The Neuroscientist 2003, 9:5-9.